There are 2934 resources available
4379 - Results of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanoma
Presenter: Maartje Rohaan
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
2096 - Clinical study of personalized neoantigen peptide vaccination in advanced NSCLC patients
Presenter: Xueming Du
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
4638 - Health-Related Quality of Life (HRQoL) Impact of Pembrolizumab (P) Versus Chemotherapy (C) as First-Line (1L) Treatment in PD-L1–Positive Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Presenter: Eric Van Cutsem
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
5708 - Chemotherapy for Frail and Elderly Patients (pts) with Advanced Gastroesophageal Cancer (aGOAC): Quality of Life (QoL) results from the GO2 Phase III Trial
Presenter: Peter Hall
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
6574 - Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Presenter: Ahmed Kaseb
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
5184 - Perioperative FLOT + anti-PD-L1 avelumab (FLOT-A) chemo-immunotherapy in resectable oesophagogastric adenocarcinoma (OGA): safety and biomarker data from the ICONIC trial safety run-in
Presenter: Michael Davidson
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4511 - POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)
Presenter: Pascal Hammel
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4623 - Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240
Presenter: Philippe Merle
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
3561 - Comprehensive Genomic Profiling (CGP) of mixed hepatocellular cholangiocarcinomas (cHCC-CCA)
Presenter: Karthikeyan Murugesan
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4537 - Outcomes based on plasma biomarkers for the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)
Presenter: Lorenza Rimassa
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract